1.430 s

+0.030 (+2.14%)
Range 1.400 - 1.470   (5%)
Open 1.410
Previous Close 1.400
Bid Price 3.800
Bid Volume 47,100
Ask Price 3.810
Ask Volume 76,900
Volume 25,689
Value -
Remark s
Delayed prices. Updated at 29 Mar 2024 03:59.
Data powered by
View All Events

About ORAGENICS INC

Oragenics, Inc. is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits. The Company is developing and seeking partners or commercializing four products, including ProBiora3, LPT3-04, SMaRT Replacement Therapy and MU1140-S. The Company is focusing its efforts on growing its oral probiotic business both with its branded Evora products and through licensing and private label sales (with ProBiora3). Its SMaRT Replacement Therapy is designed to be a treatment applied to the teeth that has the potential to offer protection against dental caries, or tooth decay.

There are 3 followers

Followers
0
Followers
0
Followers
74